Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00564070 · ClinicalTrials.gov registry record · NA
CBT for Adherence and Depression in Diabetes
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT00564070: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00564070 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00564070, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of cognitive behavioral therapy (CBT) in treating people with depression and type 2 diabetes.
Interventions
- BEHAVIORAL Enhanced treatment as usual plus adherence training
- BEHAVIORAL Enhanced treatment as usual plus CBT-AD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00564070
The ClinicalTrials.gov registry entry for NCT00564070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced treatment as usual plus adherence training is the first listed.
NCT00564070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00564070 about?
NCT00564070 is a clinical study titled "CBT for Adherence and Depression in Diabetes". This study will evaluate the effectiveness of cognitive behavioral therapy (CBT) in treating people with depression and type 2 diabetes.
What is the current status of trial NCT00564070?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2007-06. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00564070?
The interventions under investigation include: Enhanced treatment as usual plus adherence training (BEHAVIORAL), Enhanced treatment as usual plus CBT-AD (BEHAVIORAL).
Who is sponsoring clinical trial NCT00564070?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.